89BIO (ETNB)
(Delayed Data from NSDQ)
$8.58 USD
-0.34 (-3.81%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $8.63 +0.05 (0.58%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | 5.66% |
ABR | 1.40 |
Earnings ESP
|
-18.75% |
---|---|
Current Year | -2.20 |
Next Year | -2.86 |
EPS (TTM) | -2.01 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.52 | -2.20 | -2.86 |
# of Estimates | 4 | 3 | 6 | 5 |
Most Recent Consensus | -0.44 | -0.49 | -1.85 | -2.70 |
High Estimate | -0.42 | -0.46 | -1.79 | -2.11 |
Low Estimate | -0.57 | -0.60 | -2.82 | -3.40 |
Year ago EPS | -0.54 | -0.52 | -2.00 | -2.20 |
Year over Year Growth Est. | 11.11% | 0.00% | -10.00% | -29.91% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.52 | -2.20 | -2.86 |
7 Days Ago | -0.48 | -0.52 | -2.20 | -2.86 |
30 Days Ago | -0.48 | -0.52 | -2.20 | -2.86 |
60 Days Ago | -0.58 | -0.66 | -2.56 | -3.09 |
90 Days Ago | -0.62 | -0.70 | -2.60 | -3.08 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.52 | -2.80 | -3.40 |
Zacks Consensus Estimate | -0.48 | -0.52 | -2.20 | -2.86 |
Earnings ESP | -18.75% | 0.00% | -27.27% | -18.96% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | -0.45 | -0.52 | -0.54 | NA |
Estimate | -0.53 | -0.50 | -0.41 | -0.56 | NA |
Difference | 0.03 | 0.05 | -0.11 | 0.02 | 0.00 |
Surprise | 5.66% | 10.00% | -26.83% | 3.57% | -1.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more